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Introduction
It is well known that the choroidal
circulation exerts a vital role in the
metabolic support of the retina and its
abnormalities. The choroidal circula-
tion evokes different pathological con-
ditions by either hyperperfusion or
hypoperfusion of the retina, such as
exudative retinal detachment or retinal
ischaemia, respectively.
Dysfunction in ocular circulation is
related to a wide range of disease pro-
cesses that involve changes in the eye
vascular profile (Roff et al. 1999),
such as glaucoma, age-related macular
degeneration (AMD) and diabetes. In
diabetes, metabolic factors other than
blood glucose are suspected to be
involved in the impairment of retinal
autoregulation (Jeppesen et al. 2007).
Despite the different studies and
methodologies used to understand
choroidal circulation, several aspects
of its physiology are not yet well
understood, mainly because the cho-
roid is inaccessible to direct visualiza-
tion and to the interference, in
humans and other animal species, of
retinal circulation. As there is putative
or no innervation (Foulds 1990) in the
retinal vasculature as well as in the
vascular system feeding the optic
nerve head, the retinal circulation is
controlled by autoregulatory mecha-
nisms (Delaey & Van der Voorde
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ABSTRACT.
Purpose: We aimed to investigate the responsiveness of the ocular arteries to
adrenergic drugs in a model of perfused isolated rabbit eye.
Methods: Rabbit external ophthalmic arteries (n = 15) in a head-mounted
preparation were cannulated and the retinal and uveal vasculature perfused at
a constant flow with warmed tyrode. The three-way polypropylene catheter
was further connected to a pressure transducer and intraluminal pressure was
taken as a measure of vascular resistance. Effects of intra-arterial injections
of phenylephrine (group A, n = 5), prazosin (group B, n = 5) and phentol-
amine (group C, n = 5) on the recorded pressure were obtained. Student’s
paired-t test and one-way analysis of variance were used for statistical analysis
(p < 0.05).
Results: Intrinsic vasomotricity was observed in all preparations prior to any
drug administration. Phenylephrine produced an increase in total vascular
resistance. Intrinsic vasomotricity became more evident, showing a lower
frequency but higher amplitude of oscillations. Evoked vasomotor responses
with phenylephrine (250 lg ⁄ml) were inhibited by intra-arterial administration
of the selective a1-adrenergic antagonist, prazosin (0.5 mg ⁄ml), as well as the
non-selective a-adrenergic antagonist phentolamine (6 mg ⁄ml).
Conclusions: Rabbit external ophthalmic arteries showed spontaneous contrac-
tions under constant perfusion. Phenylephrine elicited a vasoconstrictor
response that was inhibited by adrenergic antagonists. In addition, the intrinsic
vasomotricity was enhanced by phenylephrine and blocked by adrenergic
antagonists. These results show that under in vitro perfusion the territory pre-
sents similar responses to adrenergic drugs to those observed in in vivo models
and also provides evidence of myogenic autoregulatory properties in the rabbit
ophthalmic artery and ⁄or choroid.
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2000a) whereby endothelial cells play
an important role in regulating vascu-
lar tone by secreting constricting and
relaxing factors (Hardy et al. 2001;
Okuno et al. 2002). However, contro-
versy still exists on the extrinsic con-
trol mechanisms of choroidal
circulation. In fact, choroidal blood
flow is autoregulated (Kiel 1994, 2000;
Kiel & van Heuven 1995; Riva et al.
1997; Hardy et al. 2000), but is also
controlled by choroidal perivascular
autonomic innervation, which depends
on the sympathetic system, originating
from the superior cervical ganglion,
parasympathetic system originating
from the ciliary ganglion, and the sen-
sory system (from the trigeminal gan-
glion) (Bill & Sperber 1990; Kiel 1999;
Delaey & Van der Voorde 2000a).
Parasympathetic nerve stimulation
produces nitric oxide-mediated vaso-
dilation, which appears to be selective
to vessels in the anterior choroid
(Mann et al. 1995; Steinle et al. 2000)
and sympathetic nerves elicit mar-
ked vasoconstriction throughout the
choroidal vessels via a-nor-adrener-
gic mechanisms (Steinle et al. 2000).
Therefore, autonomic nerves exert
short-term regulatory effects on cho-
roidal blood flow by changing vascu-
lar smooth muscle tone.
In an in vivo model of ocular circu-
lation, interferences of stimuli origi-
nating outside the eye can occur,
elicited by changes in the autonomic
balance and peripheral circulation.
The purpose of this work was to
develop an experimental model of iso-
lated rabbit eye in order to abolish the
neural control of ocular blood flow.
The isolated perfused eye technique
was pioneered by Gouras & Hoff
(1970) and further refined by Nie-
meyer (2001). In vitro functional stud-
ies of ophthalmic circulation involving
either the perfusion of the whole eye
or the study of isolated arterial seg-
ments – ophthalmic, ciliary, choroidal
or retinal (Yu et al. 2003) – allow for
assessment of the vasoactive proper-
ties of the ocular vasculature without
necessitating undesirable external
interferences within the preparation.
This study aimed to develop an
in situ isolated eye preparation that
could be used to understand patho-
physiological changes in the dynamics
of the ocular circulation, particularly
with respect to its local autoregulatory
mechanisms, independently of neural
control. We tested this model using
adrenergic drugs of known effects.
Materials and Methods
Anaesthesia and general surgical
procedures
New Zealand White rabbits (n = 15)
of both sexes (body weight: 2.0–
4.2 kg) were anaesthetized with
sodium pentobarbitone (40 mg ⁄kg,
i.v.) supplemented as necessary (10%
v ⁄ v of the induction solution). A
tracheotomy was performed low in
the neck to allow artificial ventilation
with O2-enriched air using a positive
pressure ventilator (Harvard Appara-
tus Ltd, Kent, UK). In the neck, the
carotid and the jugular vein were
cannulated to allow the monitoring of
arterial blood pressure and the admin-
istration of warm saline and drugs,
respectively. The electrocardiogram
(ECG) was recorded by placing intra-
dermic electrodes in three of the four
limbs. Body temperature was moni-
tored and kept constant (38–39 C)
using a heating blanket (Harvard
Apparatus Ltd), 1000 IU ⁄kg heparin
was administered to prevent clotting,
and a waiting time of 30 mins was
observed. The animals were then
killed with an overdose of anaesthetic
and their heads flushed via the carotid
artery with 200 ml warm tyrode solu-
tion. Immediately afterwards, the head
was sectioned at cervical level, placed
in a Petri dish lined with gauze swabs
and immersed in freshly prepared
tyrode. The head was held in position
to expose the ophthalmic artery and
continuously perfused with warm
tyrode solution enriched with O2
through the catheter placed in the car-
otid artery. The medulla and pons
were destroyed.
All experimental procedures con-
formed to the tenets of the Helsinki
Declaration.
Model development
To access the ophthalmic artery, the
masseter, part of the mandibular bone
and the zygomatic arch were removed.
After that the external ophthalmic
artery was exposed, incised and a poly-
propylene tube with an outside diame-
ter of 0.6 mm was placed in the vessel.
A dissecting microscope facilitated the
procedure. The catheter was further
secured with sutures of 7–0 silk, and
the remaining collateral vessels were
ligated. The external ophthalmic artery
was perfused with O2-enriched warmed
tyrode delivered to the catheter by
continuous i.v. infusion apparatus
(series 81706; Semat Technical Ltd,
London, UK) with a flow rate of
135 ll ⁄min. The three-way polypropyl-
ene catheter was further connected to
a pressure transducer (Neurolog; Digi-
timer Ltd, Hertfordshire, UK) and the
perfusion pressure at the external oph-
thalmic artery was measured. To avoid
dryness and further muscle contrac-
tions the head was maintained
immersed in a glass chamber contain-
ing warm O2-enriched tyrode at a con-
stant temperature of 38 C and
controlled pH (range 6.9–7.4). The
bath solution was replaced during the
experiment to avoid agonist build-up.
Considerable care and effort was spent
on a series of preliminary experiments
aimed at achieving a perfused eye in
the optimal physiological condition, in
which we investigated choice of per-
fusate, flow rate, perfusion pressure
and volume of agonist.
Model testing
Once perfusion commenced, an equili-
bration period was allowed, and no
agonist delivery was attempted until
the baseline perfusion pressure was
stable, showing a consistent medium
perfusion pressure value. After stabil-
ization of the preparation, a vehicle
control injection of 0.1 ml tyrode was
given through the catheter placed in
the ophthalmic artery to view the injec-
tion artefact and the null response.
Three types of experimental proce-
dures involving the injection of drugs
affecting the sympathetic nervous sys-
tem were performed in different animal
heads. In order to evaluate the specific-
ity of the response to each drug, a per-
iod of time (approximately 15 mins)
was allowed to elapse between each
injection before the effect of a new
drug was assessed. This period allowed
us to establish a consistent baseline
medium perfusion pressure value,
allowing for a slight variation that
could reflect receptor saturation. At
the end of each experiment, a calibra-
tion curve was performed and methy-
lene blue dye was injected through the
ophthalmic artery to confirm eye per-
fusion by blue staining.
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Injection of an a-adrenergic agent:
phenylephrine
In five experiments, 0.1 ml phenyleph-
rine was injected through the catheter
inserted in the ophthalmic artery, in
three different concentrations of
25 lg ⁄ml, 250 lg ⁄ml and 2500 lg ⁄ml,
respectively, with intervals of approxi-
mately 15 mins between injections.
Changes in ophthalmic artery perfu-
sion pressure were recorded after each
injection.
Injection of an a1 antagonist: prazosin
In another five experiments, we
administered separate injections via
the ophthalmic artery catheter of
phenylephrine (0.1 ml; 250 lg ⁄ml),
prazosin (0.1 ml; 0.5 mg ⁄ml), and a
mixture of phenylephrine (0.1 ml;
250 lg ⁄ml) and prazosin (0.1 ml;
0.5 mg ⁄ml), with intervals of approxi-
mately 15 mins between injections.
After each injection of drugs, changes
in ophthalmic artery pressure were
monitored.
Injection of an a-antagonist: phentol-
amine
In a separate set of five experiments
we delivered separate injections via
the ophthalmic artery catheter of
phenylephrine (0.1 ml; 250 lg ⁄ml),
phentolamine (0.1 ml; 6 mg ⁄ml), and
a mixture of phenylephrine (0.1 ml;
250 lg ⁄ml) and phentolamine (0.1 ml;
6 mg ⁄ml), at intervals of approxi-
mately 15 mins. Changes in ophthal-
mic artery pressure were assessed after
each injection.
Drugs
Tyrode solution comprises NaCl
(137 mM), KCl (2.7 mM), CaCl2
(1.8 mM), MgCl2 (0.49 mM), NaH2PO4
(0.36 mM), NaHCO3 (11.9 mM), glu-
cose (5.6 mM) and distilled water
(1000 mL).
The following drugs were used:
phenylephrine, prazosin and phentol-
amine (Sigma Aldrich Chemie Gmbh,
Steinheim, Germany). All drugs were
dissolved in distilled water and freshly
prepared.
Data analysis
All data were displayed online and
recorded on videotape with a speed of
acquisition of 100 Hz. Arterial blood
pressure and ECG were monitored
using the PowerLab System (Instat,
GraphPad, San Diego, CA, USA)
until the animal was killed. Ophthal-
mic artery perfusion pressure was
recorded and analysed offline using
the PowerLab System. Student’s
paired-t test and anova (one-way anal-
ysis of variance) were used for statisti-
cal analysis; differences were
considered significant when p < 0.05.
The results on the frequency of oscil-
lations were obtained by simple count-
ing over a given period. Data are
expressed as mean ± standard error
of the mean (SEM).
Results
The period between the death of the
animal and the beginning of the
experiment corresponded to 41 ±
1.14 mins in group A, 42.6 ± 1.59
mins in group B and 40 ± 0.71 mins
in group C (n = 15, p = 0.8819,
anova). Equilibration periods were
16 ± 0.71 mins in group A, 15.2 ±
0.58 mins in group B and 15.6 ±
0.51 mins in group C (n = 15,
p = 0.6562, anova). The total time
taken to conduct experiments from
the death of the animal to the end of
the experiment was 105.8 ± 1.24 mins
in group A, 107.6 ± 1.33 mins in
group B and 110.4 ± 1.40 mins in
group C (n = 15, p = 0.0841, anova
test). As p-values were > 0.05, differ-
ences were considered not significant
(i.e. the difference between means
were not significantly greater than
those expected by chance).
Basal myogenic responses
Before any drug administration, spon-
taneous myogenic responses were
observed in the 15 rabbit models. This
spontaneous vasomotion showed
oscillations of a medium frequency of
3.6 ± 0.66 oscillations ⁄min and a
medium amplitude value of
1.6 ± 0.18 mmHg (Fig. 1).
Effects of adrenergic drugs on perfusion
pressure
Effects of chemical stimulation with
phenylephrine
The arteries constricted in response to
intra-arterial deliveries of increasing
concentrations of phenylephrine (25
lg ⁄ml, 250 lg ⁄ml, 2500 lg ⁄ml). Injec-
tion of 25 lg ⁄ml phenylephrine
evoked a change which resulted in an
increase of 40% in perfusion pressure
value (n = 5, p = 0.0015); adminis-
tration of 250 lg ⁄ml phenylephrine
resulted in an increase of 57%
(n = 5, p = 0.0011), and administra-
tion of 2500 lg ⁄ml phenylephrine
resulted in an increase of 66%
(n = 5, p = 0.0021) (Fig. 2).
Statistical analysis with anova of the
variation between the basal values
before the three injections of phenyl-
ephrine showed that the variance was
not significant (p = 0.9205).
Effects of chemical stimulation with
a1-antagonist: prazosin
Phenylephrine alone induced an
increase in registered pressure of 74%
(n = 5, p = 0.0019). Administration
of prazosin elicited a decrease in oph-
thalmic pressure of 33% (n = 5,
p = 0.0040). Injection of a mixture of
phenylephrine and prazosin elicited no
difference between mean values, which
resulted in no significant increase or
decrease in perfusion pressure value
(n = 5) (Fig. 3).
Fig. 1. Example of basal periodic oscillations in vascular tone observed without any drug




Effects of chemical stimulation with
a-antagonist: phentolamine
Injection of phenylephrine evoked an
increase in perfusion pressure of 42%
(n = 5, p = 0.0089). Administration
of phentolamine resulted in a decrease
in pressure of 19% (n = 5,
p = 0.0053), and injection of a mix-
ture of phenylephrine and phentol-
amine resulted in a slight decrease of
2% (n = 5, p = 0.0487) (Fig. 4).
Effects of adrenergic drugs on myogenic
responses
Effects of chemical stimulation with
phenylephrine
In terms of myogenic response, the
initial injection of phenylephrine in all
15 rabbit models resulted in a
decrease of 61% in the frequency of
oscillations (n = 15, p = 0.0004).
However, the initial injection of phen-
ylephrine elicited an increase of 58%
in the amplitude of oscillations
(n = 15, p = 0.0001) (Figs. 5 and 6).
Effects of chemical stimulation with
a1-antagonist: prazosin
In terms of myogenic activity, injec-
tion of prazosin evoked a decrease of
69% in the frequency of oscillations
(n = 5, p = 0.0161) and a decrease of
75% in the amplitude of oscillations
(n = 5, p = 0.0061) (Figs. 5 and 6).
Effects of chemical stimulation with
a-antagonist: phentolamine
In terms of myogenic responses, phen-
tolamine injection evoked a decrease
of 53% in the frequency of oscilla-
tions (n = 5, p = 0.0014) and a
decrease of 77% in the amplitude of
oscillations (n = 5, p = 0.0003)
(Figs 5 and 6). Trace examples are
shown (Figs. 7–9).
Discussion
The purpose of this study was to
increase our understanding of the con-
trol of ocular circulation. We devel-
oped an experimental model of an
isolated rabbit eye in order to avoid
the neural control of ocular blood
flow and to assess local autoregulato-
ry mechanisms.
To test the reliability of our model,
we used adrenergic drugs with known
vasoconstricting and vasodilating
effects. Our purpose was not to define
a dose-dependent relationship or to
Fig. 3. Changes in perfusion pressure through the external ophthalmic artery after injection of
phenylephrine (Phe) 250 lg ⁄ml, prazosin (Praz) 0.5 mg ⁄ml and phenylephrine 250 lg ⁄ml plus
prazosin 0.5 mg ⁄ml. Data are expressed as mean ± standard error of the mean. Black bars
show control values; white bars show response values (p < 0.05).
Fig. 2. Changes in perfusion pressure through the external ophthalmic artery after injection of
three different doses of phenylephrine: 25 lg ⁄ml, 250 lg ⁄ml and 2500 lg ⁄ml. Data are
expressed as mean ± standard error of the mean. Black bars show control values; white bars
show response values (p < 0.05).
Fig. 4. Changes in perfusion pressure of external ophthalmic artery after the injection of phen-
ylephrine (Phe) 250 lg ⁄ml, phentolamine (Phento) 6 mg ⁄ml and phenylephrine 250 lg ⁄ml plus
phentolamine 6 mg ⁄ml. Data are expressed as mean ± standard error of the mean. Black bars
show control values; white bars show response values (p < 0.05).
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perform a pharmacological study. In
fact, for the validation process, we
studied systematically, and qualita-
tively rather than quantitatively, the
effect of a vasoactive constricting drug
(phenylephrine), the effects of two cat-
ecolaminergic antagonists and, in a
third stage, the combined effect of
phenylephrine and each of the catecol-
aminergic antagonists.
Briefly, our results show that
administration of phenylephrine insti-
gated an increase in pressure in the
ophthalmic artery. By contrast, after
injection of the two catecolaminergic
antagonists, a decrease in ophthalmic
pressure was observed. The combined
effect of phenylephrine with the
antagonist showed that the vasocon-
stricting effect of phenylephrine was
partially inhibited by the catecolamin-
ergic antagonist. Administration of an
a1- versus an a-antagonist did not eli-
cit significant differences in the
observed pressure responses, thus sug-
gesting, together with previous studies
(Van Pixteren 1985; Koss & Gher-
ezghiher 1993; Kiel & Lovell 1996;
Kawarai & Koss 1998), the presence
of an a1-mediated vasoconstriction
mechanism in rabbit eye circulation.
One major finding of this study was
the presence of spontaneous myogenic
activity in the rabbit ophthalmic
artery in vitro.
Vasomotion refers to periodic oscil-
lations in vascular tone that ensure
the intermittent supply of blood to
adjacent microvascular units. Several
studies in isolated porcine (Hoste
et al. 1989; Nyborg et al. 1990; Yu
et al. 1994; Hessellund et al. 2003;
Jeppesen et al. 2003) or bovine (De-
laey & Van de Voorde 2000b) retinal
arteries studied in a myograph suggest
that there are basal oscillations in vas-
cular tone. Another study revealed
myogenic tone and reactivity of iso-
lated rat external ophthalmic artery
(Jarajapu et al. 2004).
To our knowledge, this is the first
report of spontaneous vasomotion in
the rabbit external ophthalmic artery
and its collaterals in an isolated
model of rabbit eye. Our isolated
eye model maintains the arterial and
venous vascular connections, which
probably allows a more correct visu-
alization of these oscillations than an
isolated artery. Moreover, the low
perfusion pressure present in our model
probably elicits an autoregulatory
Fig. 5. Changes in frequency of the oscillations of the myogenic response through the external
ophthalmic artery after injection of phenylephrine (Phe) 250 lg ⁄ml (n = 15), prazosin (Praz)
0.5 mg ⁄ml (n = 5), and phentolamine (Phento) 6 mg ⁄ml (n = 5). Data are expressed as
mean ± standard error of the mean. Black bars show the medium of the frequency values
before drug injections; white bars show the values after drug injections (p < 0.05).
Fig. 6. Changes in amplitude of oscillations of the myogenic response through the external
ophthalmic artery after injection of phenylephrine (Phe) 250 lg ⁄ml (n = 15), prazosin (Praz)
0.5 mg ⁄ml (n = 5) and phentolamine (Phento) 6 mg ⁄ml (n = 5). Data are expressed as
mean ± standard error of the mean. Black bars show the medium of frequency values before
drug injections; white bars show the values after drug injections (p < 0.05).
Fig. 7. Example of changes in vascular tone observed after a phenylephrine injection. There is
marked vasoconstriction as well as a decrease in frequency and increase in amplitude of oscilla-
tions. Perfusion pressure was recorded at the rabbit external ophthalmic artery (in mmHg).
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vascular response in rabbit ocular
circulation. This response probably
exists to respond to hypotensive situa-
tions to prevent ischaemia of the ocular
tissues or it may regulate ocular blood
perfusion in cases of systemic hyperten-
sion that, fortunately, are not cor-
related with situations of ocular
hypertension.
Elsewhere in the circulation, myo-
genic autoregulation performs an
important homeostatic function by
maintaining capillary hydrostatic pres-
sure during fluctuations in arterial
pressure. By stabilizing capillary pres-
sure, myogenic autoregulation also
minimizes arterial pressure-dependent
changes in blood volume downstream
from the resistance vessels. Because it
takes changes in ocular volume of
only microlitres to produce significant
changes in intraocular pressure (IOP),
it is possible that choroidal myogenic
autoregulation stabilizes IOP during
the normal transient variations in sys-
temic arterial pressure associated with
daily activities (Kiel 1994).
In general, in studies that decreased
the perfusion pressure by increasing
IOP while maintaining a constant
mean arterial pressure (MAP), no au-
toregulation was found. By contrast,
the study by Kiel & Shepperd (1992)
found autoregulation when the perfu-
sion pressure was decreased by lower-
ing the MAP and holding the IOP
constant at 15 mmHg and 5 mmHg in
rabbits. However, even more pro-
nounced autoregulation was found in
a later study (Kiel 1994), when perfu-
sion pressure was varied by raising
and lowering the MAP without con-
trolling the IOP. These findings sug-
gest that MAP may be a better
stimulus to elicit choroidal autoregula-
tion than IOP, and that the failure of
previous studies to observe choroidal
autoregulation might be related to
their use of IOP to vary ocular perfu-
sion pressure. Such a mechanism
might be beneficial in stabilizing IOP
during MAP fluctuations that are too
brief for aqueous compensation to
respond to (Kiel 1994).
The vasospastic syndrome corre-
sponds to a contraction of the muscle
cells of the arterial wall and is thought
to be correlated with a higher preva-
lence of ocular ischaemic diseases
(Gasser & Flammer 1987; Gasser
1999). These patients exhibit faster
pulse waves in the retinal vessels
(Gugleta et al. 2006), which may cor-
respond to a stronger intrinsic myo-
genic tone.
In our study, myogenic behaviour
was modulated by adrenergic drugs.
The observed increase in the ampli-
tude of the oscillations of myogenic
vascular tone with phenylephrine and
the blunting of myogenic responsive-
ness with the adrenergic antagonists
which lowered the frequency and
amplitude of the oscillations indicate
that neural sympathetic regulation
superimposes on local myogenic auto-
regulation.
This study provides evidence that
the rabbit ocular vasculature exhibits
autoregulatory myogenic tone in
response to a low perfusion pressure.
Our results were obtained under con-
stant flow conditions, which are
expected to modulate the arterial
diameter through endothelial mecha-
nisms (Meyer et al. 1993). Thus, we
believe the intrinsic vasomotricity
observed depends on the influences of
both myogenic tone and endothelium
regulation.
The experimental design cannot
determine the arterial segment respon-
sible for the myogenic tone. Clinical
studies use ophthalmic artery haemo-
dynamics as a measure of the overall
function of ophthalmic circulation
(Krejcy et al. 1997; Yu et al. 2003; Ito
et al. 2006). However, because of its
merangiotic type of retinal circulation,
the rabbit is commonly used as a
model for choroidal studies; therefore,
we believe that although the ophthal-
mic artery might be involved, the
most significant change in resistance
occurs in the smaller vessels in the
choroid.
Our results confirm our experimen-
tal model of the isolated perfused eye
as a reliable model with which to
study local regulatory mechanisms of
choroidal circulation. Its reliability
has been proved by the vascular
responses elicited by the administra-
tion of drugs into the ophthalmic
artery in the absence of extrinsic fac-
tors such as nervous control or
Fig. 8. Example of changes in vascular tone observed after a phentolamine (a-blocker) injec-
tion. There is vasodilatation as well as a decrease in frequency and amplitude of oscillations.
Perfusion pressure was recorded at the rabbit external ophthalmic artery (in mmHg).
Fig. 9. Example of a trace of a whole experiment, from the prazosin group. We can see that
the phenylephrine injection elicited an increase in perfusion pressure, prazosin produced a
decrease and the injection of both drugs together did not cause any change in PP. Perfusion
pressure was recorded at the rabbit external ophthalmic artery (in mmHg).
Acta Ophthalmologica 2008
6
systemic blood pressure. We believe
that this isolated perfused rabbit eye
represents a valuable technique for
investigating the vascular reactivity of
eye circulation.
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